期刊文献+

补肾中药诱导骨髓基质干细胞成骨分化的动物实验研究 被引量:1

Study on kidney-reinforcing herbal medicine induce bone marrow stem cells to osteoblast cells:an animal experiments
下载PDF
导出
摘要 目的通过动物实验于体外条件下观察补肾中药对大鼠骨髓基质干细胞增殖分化的影响。方法将不同浓度的补肾中药方剂与骨髓基质干细胞体外共同培养,测定细胞增殖功能,检测成骨细胞增殖与分化指标(包括碱性磷酸酶、矿化结节)。结果与空白组比较,浓度100 mg/L、200 mg/L的补肾中药在不同时间段均可提高骨髓基质干细胞增殖率(P<0.05);与空白组比较,浓度20 mg/L、40 mg/L、100 mg/L、200 mg/L的补肾中药可使ALP活性增强、矿化结节数量增多(P<0.05)。结论较高浓度的补肾中药能促进骨髓基质干细胞的成骨潜能。 Objective To study the effects of kidney-reinforcing herbal medicine on the differentiation and proliferation of osteoblasts under in vitro conditions. Methods Culture the MSCs and the kidney-reinforcing herbal medicine respectively at the concentrations of 0 mg/L, 1 mg/L, 10 rag/L,20 mg/L,40 mg/L, 100 mg/L,200 mg/L in vitro ;and then evaluation cells proliferation function and detect osoteoblasts indicators such as activity of alkaline phosphatase (ALP) and the mineral node number. Results There is a significant difference in the cell proliferation rate between the high concentrations (100 mg/L, 200 mg/L) with the blank group at any time (P 〈 0.05); the concentrations of 20 mg/L, 40 mg/L, 100 mg/L,200 mg/L groups can elevate ALP activity and improve the mineral node number. Conclusion The higher level of kidney-reinforcing herbal medicine can promote the osteogenic differentiation potential of MSCs.
出处 《中国现代医生》 2013年第8期1-3,共3页 China Modern Doctor
基金 浙江省中医药管理局项目(2010ZB099)
关键词 补肾中药 骨髓基质干细胞 碱性磷酸酶 矿化结节 Kidney-reinforcing herbal medicine Bone marrow stromal cells ALP Mineral node
  • 相关文献

参考文献12

二级参考文献41

共引文献254

同被引文献20

  • 1童培建,厉驹,瞿杭波,陈峥嵘.经皮自体骨髓间充质干细胞移植治疗四肢骨折骨不连[J].中华创伤杂志,2007,23(7):499-501. 被引量:25
  • 2Khojasteh A,Behania H,Dashti SG, et al. Current trends in mes- enchymal stem cell application in bone augmention:a review of the literature[J]. J Oral Maxillofac Surg,2012,70(4) :972-982.
  • 3Peng Q, Jiang F, Huang P, eta/. A novel porous bioceramics scaffold by accumulating hydroxyapatite spherules for large bone tissue engi- neering in vivo. I. Preparation and characterization of scaffold [J]. Biomed Mater Res,2010,93(3):920-929.
  • 4Tan SL,Ahmad TS,Selvaratnam L,et 8]. Characterization and the multi-lineage differentiation potential of rabbit bone marrow-derived mesenchymal stem cells[J]. J Anat,2013,222(4) :437-450.
  • 5Charbord P. Bone marrow mesenchymal stem cells:historical overview and concepts[J]. Hum Gene Tber,2010,21(9): 1045-1056.
  • 6Fridenstein Ala,PiatetskiT-Shapiroll,Petrakova KV. Osteogenesis in transplants of bone marrow ceils [J]. Arkh Anat Gistol Embriol, 1969,56(3) : 3-11.
  • 7Sudo K, Kanno M, Miharada K, et a/. Mesenchymal progenitors able to differentiate into osteogenic,chondrogenic,and/or adipogenic cells in vitro are present in most primary fibroblast-like cell popu- lations[J]. Stem Ceils, 2007,25(7) : 1610-1617.
  • 8Karlsen TA,Jakobsen RB,Mikkelsen TS,et a/. MicroRNA-140 targers RALA and regulates chondrogenic differentiation of hunman esenchymal stem ceils by translational enhancement of SOX9 and ACAN[J].Stem Ceils Dev, 2014,23(3) : 290-304.
  • 9Zhou J,Lin H,Fang T,et a/. The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone [J]. Biomateriais, 2010,3 t(6) : 1 !71-1 t79.
  • 10Hao PJ,Wang ZG,Xu QC,et al. Effect of umbilical cord mes- enchymal stem cell in peri-implant bone defect after innmediate implant :an experiment study in beagle dogs [J]. Int J Clin Exp Med, 2014,7(11) :4131-4135.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部